The following post is by The Global Center’s Christine Lubinski, reporting from the 18th International AIDS Conference in Vienna. Michel Sidibe, Director of UNAIDS, and Marcos Espinal, Director of the STOP TB Partnership, signed a memorandum of understanding at a TB/HIV symposium today, pledging to join forces to reduce the human toll of HIV/TB co-infection. […]
The following post is by HIVMA Executive Director Andrea Weddle, reporting from the 18th International AIDS Conference in Vienna. In another late breaker session Thursday, French researcher Blanc presented data supporting early initiation of HIV treatment for patients co-infected with HIV/TB and suggesting it could reduce deaths in co-infected patients by 33 percent. The results […]
The following post is by HIVMA Executive Director Andrea Weddle. She is on location in Vienna, reporting from the 18th International AIDS Conference. South African researcher Meyer-Rath presented compelling data on the cost effectiveness of treating infants early in South Africa at an IAS 2010 late breaker session on Thursday. The findings were based on […]
This post is by the Global Center’s Christine Lubinski, reporting from the International AIDS Conference in Vienna. This is a summary of a report released at a session on Thursday by E. Odoyo-June and colleagues. Kisumu is the third largest city in Kenya and was the site of one of the three critical clinical trials […]
Vienna — “Today, only 4.1 percent of people living with HIV/AIDS are screened for TB,” said RESULTS Executive Director Joanne Carter during a press conference Wednesday at IAS 2010. “And this is despite TB being the most likely infection to kill [HIV infected persons.]” “Failure to provide this screening is malpractice on the grandest scale,” […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]